AI assistant
LG Electronics Incorporated — AGM Information 2022
Mar 2, 2022
10825_nav_2022-03-02_315d26ba-5a9a-4a11-b6ea-fedf6c6bad4e.html
AGM Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 3462D
LG Electronics Incorporated
02 March 2022
2022 LG Electronics AGM Statement
Date and location
• Date : AM 9:00 March 24th (Thursday), 2022
• Location : Main Auditorium (B1), East Wing of LG Twin Towers
Agenda
| Agenda 1 : Approval of Proposed FY 2021 Financial Statements | ||
| - Dividend per share : Common Stock 850 KRW, Preferred Stock 900 KRW | ||
| Agenda 2 : Approval of Amendment of Article of Incorporation | ||
| - - - - |
In order to sell medical devices, 'medical device manufacturing and sales business' is to be added in accordance with the Medical Device Act Addition of 'licensing business of intellectual property rights such as patents' to continue the intellectual property rights licensing business such as mobile patents, which has been carried out incidentally by the MC business Addition of 'development and sales of blockchain-based software, and trading and brokerage of cryptographic assets' to provide blockchain platform services 'Production and sales of functional materials such as glass powder' is to be added to manufacture/sell functional glass materials (enamel and antibacterial functional glass powder) |
|
| Agenda 3 : Appointment of Directors | ||
| - Agenda 3-1 : Outside Director Sang-Goo Lee (Re-appointment) - Agenda 3-2 : Outside Director Choong-Yuel Yoo (New appointment) |
||
| Agenda 4 : Appointment of Audit Committee Member | ||
| - Agenda 4-1 : Audit Committee Member Sang-Goo Lee (New appointment) - Agenda 4-2 : Audit Committee Member Choong-Yuel Yoo (New appointment) |
||
| Agenda 5 : Approval of Compensation Limit for Directors | ||
| - Compensation Limit 9.0 Billion KRW (Previous Year : 9.0 Billion KRW) | ||
http://www.rns-pdf.londonstockexchange.com/rns/3462D_1-2022-3-2.pdf
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMBKBBNABKKANK